Consolidated Statements of Changes in Shareholders’ Equity - USD ($) $ in Thousands	Total		Cumulative Effect, Period of Adoption, Adjustment	Unallocated Common Stock Held by ESOP	Common Stock	Additional Paid-In Capital	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Treasury Stock	Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period (in shares) at Dec. 31, 2021					28,522,500
Balance at beginning of period at Dec. 31, 2021	$ 429,471			$ (21,905)	$ 285	$ 282,006	$ 169,457		$ 0	$ (372)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	2,396						2,396
Other comprehensive income (loss)	(24,347)	[1]								(24,347)
Purchase of Treasury stock (in shares)					(1,298,762)
Purchase of Treasury stock	(15,618)								(15,618)
Treasury stock allocated to restricted stock plan, net of forfeitures (in shares)					299,481
Treasury stock allocated to restricted stock plan, net of forfeitures	0					(3,456)	(90)		3,546
Compensation cost for stock options and restricted stock	664					664
ESOP shares committed to be released (91,272 shares)	$ 1,152			912		240
Balance at end of period (in shares) at Dec. 31, 2022	27,523,219				27,523,219
Balance at end of period at Dec. 31, 2022	$ 393,718			(20,993)	$ 285	279,454	171,763		(12,072)	(24,719)
Balance at end of period (Accounting Standards Update 2016-13) at Dec. 31, 2022			$ (18)					$ (18)
Balance at end of period (Accounting Standards Update 2022-02) at Dec. 31, 2022			$ (8)					$ (8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(7,397)						(7,397)
Other comprehensive income (loss)	1,839	[1]								1,839
Purchase of Treasury stock (in shares)					(3,717,949)
Purchase of Treasury stock	(36,268)								(36,268)
Treasury stock allocated to restricted stock plan, net of forfeitures (in shares)					704,680
Treasury stock allocated to restricted stock plan, net of forfeitures	0					(8,324)			8,324
Compensation cost for stock options and restricted stock	2,879					2,879
ESOP shares committed to be released (91,272 shares)	$ 895			913		(18)
Balance at end of period (in shares) at Dec. 31, 2023	24,509,950				24,509,950
Balance at end of period at Dec. 31, 2023	$ 355,640			$ (20,080)	$ 285	$ 273,991	$ 164,340		$ (40,016)	$ (22,880)

[1] Includes a deferred tax valuation allowance equal to the net tax benefit.